Satiety hormone may decrease risk of Alzheimer's disease

Research, published inNeurobiology of Aging, suggests that individuals with high levels of the satiety hormone, cholecystokinin, may have a lower risk of developing Alzheimer's disease.Science Daily
Source: Society for Endocrinology - Category: Endocrinology Source Type: news